Clinical Trial Update: A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC) [Phase 1]

View source ↗

Summary

This clinical trial update reports that HS-10504 is being studied in a Phase 1 trial for patients with locally advanced or metastatic non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HS-10504

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Locally Advanced or Metastatic NSCLC | Phase 1 | Status: RECRUITING